Vedanta Shares Recover from Day’s Low After Q4 FY25 Results Date Announcement

On Friday, April 25, Vedanta share price dropped over 2% due to overall weakness in the Indian stock market. The stock touched a low of ₹409.65 on the BSE, down by 2.51%. This fall came as both the Sensex and the Nifty 50 also slipped around 1%.

Partial Recovery During the Day

Vedanta shares opened higher at ₹422.05 compared to the previous close of ₹420.20. After falling during intraday trade, they bounced back slightly and even touched a high of ₹425.70. However, they remained in the red. By 1:50 PM, the stock was down 1.06%, trading at ₹415.75.

Read More, Sensex Crashes 1,200 Points; Nifty Falls 400 Points: Why Are Indian Stocks Falling Today?

Q4 FY25 Results to Be Announced on April 30

Vedanta announced that its board will meet on Wednesday, April 30, 2025, to approve the financial results for the fourth quarter of FY25 (January–March 2025) and for the full financial year (FY 2024–25).

In a stock exchange filing, the company said, “…the meeting of the Board of Directors of the Company will be held on April 30, 2025, to consider the audited financial results for the quarter and year ended March 31, 2025.”

Trading Window Closed Till May 2

Vedanta also mentioned that the trading window for insiders and designated persons will remain closed from April 1 to May 2, 2025, in line with regulations.

Vedanta Share Performance Overview

• Past 1 month: Down 10%

• Year-to-date (2025): Down over 6%

• Past 1 year: Up over 9%

• Past 2 years: Up 50%

• Past 5 years: Up 434%, giving multibagger returns

Despite short-term volatility, Vedanta shares have shown strong long-term growth.

Conclusion

While Vedanta’s stock faced pressure due to broader market trends, investor sentiment may improve with the upcoming Q4 results. Long-term performance remains strong, making it a stock to watch as earnings approach.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.                         

Investments in securities market are subject to market risks, read all the related documents carefully before investing.